Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Brain shrinkage (cerebral atrophy), Decreased motor nerve conduction velocity, Shrinkage of the cerebellum (cerebellar atrophy), and Sensory ataxia and others; and very common findings: Short stature. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Brain shrinkage (cerebral atrophy), Babinski sign, Gait ataxia |
DNAJC3 encodes DnaJ heat shock protein family (Hsp40) member C3 (504 aa). Involved in the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Highest expression in Artery Aorta (44.6 TPM) and Artery Tibial (41.2 TPM).
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome is associated with mutations in the DNAJC3 gene on chromosome 13.
The DNAJC3 protein participates in Expression of DNAJC3 (p58IPK) and HyPro-polyprotein folds pathways.
DNAJC3 is classified as a druggable target (Kinase category) with score 0.0.
Genetic testing for DNAJC3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 9 always present features, 1 very common feature, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome.
2 publications have been identified in PubMed for juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome. Kisho has analyzed 1 by research type. Research spans Review / Meta-Analysis (100%).
K S PK (2025). [PMID: 39835172](https://pubmed.ncbi.nlm.nih.gov/39835172/). *Mol Genet Metab Rep*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:48 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles |
3 |
Brain shrinkage (cerebral atrophy), Shrinkage of the cerebellum (cerebellar atrophy), Atrophy/Degeneration affecting the brainstem |
Growth and development | 1 | Short stature |
Hormones | 1 | Type I diabetes mellitus |
Lab test results | 1 | Anti-islet antigen-2 antibody positivity |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Blood and immune system | 1 | Elevated hemoglobin A1c |
Arms and legs | 1 | Areflexia of lower limbs |